NPI: 1770579591 · EAGLE PASS, TX 78852 · Ambulatory Surgical Clinic/Center · NPI assigned 09/27/2005
Authorized official FILTON, STEVE controls 20+ related entities in our dataset. Read more
| Authorized Official | FILTON, STEVE (CFO, SENIOR VP) |
| NPI Enumeration Date | 09/27/2005 |
Other providers sharing the same authorized official: FILTON, STEVE
| Year | Claims | Total Paid |
|---|---|---|
| 2019 | 87 | $1K |
| 2020 | 6,187 | $440K |
| 2021 | 38,980 | $2.84M |
| 2022 | 58,731 | $4.70M |
| 2023 | 53,495 | $5.20M |
| 2024 | 27,178 | $2.62M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99284 | Emergency department visit for the evaluation and management, high severity | 11,632 | 11,259 | $6.88M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6,721 | 6,240 | $3.71M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 5,610 | 5,473 | $1.11M |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2,388 | 2,267 | $592K |
| 71045 | Radiologic examination, chest; single view | 5,280 | 5,057 | $591K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 8,455 | 8,244 | $389K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 2,442 | 2,297 | $380K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 17,472 | 8,697 | $370K |
| 71046 | Radiologic examination, chest; 2 views | 2,987 | 2,917 | $365K |
| 87430 | 8,827 | 8,636 | $204K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 8,719 | 8,454 | $189K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,444 | 1,378 | $129K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,331 | 1,247 | $91K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 911 | 883 | $87K |
| 80053 | Comprehensive metabolic panel | 11,242 | 10,129 | $83K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 12,581 | 11,347 | $71K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 1,245 | 1,167 | $69K |
| 76801 | 435 | 393 | $67K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,218 | 2,841 | $63K |
| 87420 | 2,500 | 2,441 | $56K | |
| 71250 | 948 | 911 | $34K | |
| 59025 | Fetal non-stress test | 64 | 55 | $22K |
| 81001 | 7,621 | 7,126 | $17K | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 225 | 50 | $16K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 65 | 63 | $16K |
| 83690 | 2,918 | 2,723 | $16K | |
| 84484 | 3,468 | 2,689 | $15K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 555 | 537 | $15K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 836 | 356 | $14K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 2,493 | 2,330 | $10K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 267 | 256 | $9K |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,271 | 2,089 | $9K |
| 83874 | 2,607 | 2,247 | $8K | |
| 82550 | 2,747 | 2,375 | $7K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 140 | 140 | $6K |
| 83605 | 1,300 | 1,111 | $5K | |
| 96361 | Intravenous infusion, hydration; each additional hour | 588 | 542 | $5K |
| 84703 | 467 | 440 | $5K | |
| 72125 | Computed tomography, cervical spine; without contrast material | 87 | 81 | $5K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 759 | 721 | $4K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 60 | 57 | $3K |
| 87070 | 337 | 324 | $3K | |
| 36415 | Collection of venous blood by venipuncture | 15,646 | 13,472 | $3K |
| 85610 | 1,797 | 1,661 | $3K | |
| 87040 | 1,290 | 695 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 44 | 43 | $3K |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 13 | 12 | $3K |
| 82553 | 890 | 770 | $3K | |
| 83880 | 588 | 523 | $3K | |
| 84443 | Thyroid stimulating hormone (TSH) | 996 | 975 | $2K |
| 87186 | 1,149 | 1,011 | $2K | |
| 74018 | 14 | 14 | $2K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 685 | 648 | $2K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 732 | 726 | $2K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 55 | 55 | $2K |
| 81003 | 1,139 | 1,088 | $2K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 290 | 279 | $2K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 12 | 12 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 188 | 170 | $1K |
| 80061 | Lipid panel | 1,131 | 1,122 | $1K |
| 85730 | 859 | 810 | $1K | |
| 83735 | 1,067 | 969 | $1K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 958 | 947 | $1K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 16 | 15 | $1K |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 286 | 266 | $686.70 |
| 84702 | 36 | 25 | $663.18 | |
| 82803 | 150 | 103 | $630.42 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 50 | 50 | $613.04 |
| 94664 | 17 | 16 | $546.05 | |
| 87077 | 355 | 326 | $519.23 | |
| 85027 | 212 | 195 | $504.79 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 791 | 724 | $495.85 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 83 | 82 | $438.34 |
| J7510 | Prednisolone oral, per 5 mg | 454 | 444 | $436.06 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 454 | 389 | $378.36 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 132 | 129 | $366.67 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 910 | 844 | $248.26 |
| 84030 | 26 | 25 | $188.62 | |
| 72100 | 13 | 13 | $167.19 | |
| 36600 | 14 | 14 | $156.78 | |
| 80069 | 319 | 303 | $143.47 | |
| 73564 | 14 | 13 | $135.06 | |
| 87205 | 135 | 115 | $108.02 | |
| 82570 | 322 | 297 | $99.74 | |
| 86901 | 27 | 26 | $70.04 | |
| 86900 | 27 | 26 | $70.04 | |
| 84156 | 237 | 225 | $48.03 | |
| 82150 | 29 | 26 | $36.15 | |
| 84550 | 108 | 104 | $34.44 | |
| 82962 | 1,214 | 526 | $32.01 | |
| 83540 | 37 | 37 | $25.38 | |
| 84439 | 12 | 12 | $24.72 | |
| 83550 | 36 | 36 | $22.33 | |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 14 | 12 | $15.47 |
| A9270 | Non-covered item or service | 2,067 | 1,297 | $0.00 |
| 82607 | 44 | 44 | $0.00 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 19 | 17 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 148 | 142 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 17 | 14 | $0.00 |
| 36416 | 27 | 26 | $0.00 |